Dr Ailawadhi on Non-BCMA CAR T-Cell Therapies Under Investigation in Multiple Myeloma
Sikander Ailawadhi, MD, discusses non-BCMA CAR T-cell therapies currently under investigation in multiple myeloma.
Source: onclive.com
Car Therapy Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Car Therapy Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Car Therapy Program Today - Breaking & Trending Today
Dr Ailawadhi on the Potential Sequencing of Bispecific Antibodies in Multiple Myeloma
Sikander Ailawadhi, MD, discusses key considerations for the potential sequencing of bispecific antibodies and other BCMA-directed therapies in multiple myeloma.
Source: onclive.com
Dr Ailawadhi on Iopofosine I-131 in Waldenström Macroglobulinemia
Sikander Ailawadhi, MD, oncologist, Department of Hematology, CAR T-Cell Therapy Program, Mayo Clinic, discusses how the investigational agent iopofosine I-131 may address unmet needs for patients with Waldenström macroglobulinemia.
Source: onclive.com
How Boston Is Beating the Big C
Cancer. It’s the word no patient wants to hear—but the weapons to fight it are being created right here by the world’s finest physicians.
Source: bostonmagazine.com